Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...
Cytokinetics’ $540 Million Convertible Senior Notes Offering
RIDA Chula Vista’s $1.2 Billion Development and Financing of the Gaylord Pacific Resort Hotel and Convention Center
Latham & Watkins represented RIDA Chula Vista in the transaction. The City of Chula Vista and the Port of San Diego have announced the successful completion of...
Extra Space’s $400 Million Senior Notes Offering
Latham & Watkins represented Extra Space in the offering. Extra Space Storage Inc., a leading owner and operator of self-storage facilities in the United States and a...
Travere Therapeutics’ $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the underwriters in the offering. Travere Therapeutics, Inc. executed its offering of US$275 million aggregate principal amount of 2.25% convertible senior notes due...
GlobalFoundries’ Initial Public Offering
Cleary Gottlieb Steen & Hamilton represented GlobalFoundries in the offering, while Latham & Watkins represented the underwriters. GlobalFoundries® (GF®), a global leader in feature-rich semiconductor manufacturing, announced...
Tyra Biosciences’ $172.8 Million Initial Public Offering
Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters. Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of...
Alphatec’s $275 Million Convertible Senior Notes Offering
Latham & Watkins represented Alphatec Holdings in the transaction. Alphatec Holdings, Inc. (Nasdaq: ATEC) has announced the pricing of its offering of US$275,000,000 aggregate principal amount of...